Skip to main content
. 2015 Aug 25;20(10):1140–1148. doi: 10.1634/theoncologist.2015-0143

Figure 1.

Figure 1.

Kaplan-Meier estimates for overall survival in patients with metastatic non-clear cell renal cell carcinoma treated with sunitinib, according to baseline levels of sTNF-RI (A), sVEGF-R2 (B), GRO (C), TGF-α (D), and IL-8 (E).

Abbreviations: GRO, growth-regulated oncogene; IL-8, interleukin-8; sTNF-RI, soluble tumor necrosis factor receptor I; sVEGF-R2, soluble vascular endothelial growth factor receptor 2; TGF-α, tumor necrosis factor-α.